Medical Advocates
MK-2048
 
Main Page

New and Noteworthy
Journal Data
 





 
ARV Investigational  Drugs Main New/Noteworthy Home Page      
Last Update:  March 11, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
 
July 2010
 
Journal Abstracts , Papers, and Commentaries
 
General Reports
 
  Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation
HIV-1 Integrase inhibitor.
 Bar-Magen T, Sloan RD, Donahue DA,  et al
J Virol. 2010 Jul 7
 Abstract
 

ARV Investigational  Drugs Main New/Noteworthy Home Page      

MK-2048